Dow Jones 30 Stocks SEC Filings — June 02, 2026

02-06-2026

Honeywell appointed Jillian Evanko, CEO of Duravant, to its Board as an Independent Director and Audit Committee member, effective immediately. The appointment comes ahead of the planned spin-off of Honeywell's Aerospace business on June 29, 2026, after which several directors will move to the Aerospace board. Evanko brings over 25 years of industrial and manufacturing experience, including as former CEO of Chart Industries.

• · Evanko, 48, has more than 25 years of experience across industrial and manufacturing sectors.
• · She spent nearly a decade at Chart Industries, most recently as President and CEO and prior as CFO.
• · She holds an MBA from The University of Notre Dame and a BS in Business Administration from La Salle University.
• · Following the Aerospace spin-off on June 29, 2026, Craig Arnold, Bill Ayer, Scott Davis, and Deborah Flint will join the Honeywell Aerospace board.
• · Evanko currently serves as an independent director of Greif, Inc. and previously served on boards of Chart Industries, Parker Hannifin, and Alliant Energy.

02-06-2026

U.S. Global Investors, Inc. (GROW) announced on May 29, 2026 that its previously issued financial statements for the three and nine months ended March 31, 2026 should no longer be relied upon due to an error in the calculation of weighted-average shares outstanding, which overstated basic and diluted EPS by $0.02 and $0.01, respectively. The error did not affect revenues, expenses, net income, cash flows, or financial position, and the company plans to file an amended Form 10-Q/A to restate the affected disclosures. Management identified a material weakness in internal control over financial reporting related to the error and is implementing remedial measures.

• · The error was caused by a formula omission in a supporting spreadsheet that excluded a component of shares from the summation used to calculate weighted-average shares.
• · The error did not impact revenues, expenses, net income (loss), cash flows, financial position, or shares outstanding at period end.
• · Management concluded a material weakness existed in internal control over financial reporting as of March 31, 2026, related to a failure in the operation of a review control over the weighted average shares outstanding calculation.
• · The Audit Committee discussed the matters with Grant Thornton LLP, the company's independent registered public accounting firm.
• · The company issued a press release on June 1, 2026, announcing the intent to restate EPS for the March 31, 2026 financial statements.

02-06-2026

General Fusion Inc., a fusion energy company, announced its leadership team will participate in three investor and industry conferences in June 2026 as it prepares to go public via a business combination with Spring Valley Acquisition Corp. III (SVAC). The company highlighted its LM26 fusion demonstration machine, which began operating in early 2025 and aims to achieve key fusion milestones. However, the filing contains extensive forward-looking statements cautioning about risks including potential failure to complete the business combination, inability to commercialize MTF technology, and capital raising uncertainties.

• · General Fusion was established in 2002 and is headquartered in Vancouver, Canada.
• · LM26 is the first MTF demonstration machine built at commercially relevant scale, mechanically compressing plasma with a lithium liner.
• · LM26 aims to achieve plasma heating to 1 keV (10 million degrees Celsius), then 10 keV (100 million degrees Celsius), and ultimately the Lawson criterion.
• · Spring Valley I completed a business combination with NuScale Power; Spring Valley II with Eagle Nuclear Energy Corp.
• · The business combination agreement was dated January 21, 2026, and involves SVAC continuing from Cayman Islands to British Columbia, amalgamation with NewCo, and name change to General Fusion Group Ltd.
• · The filing includes a PIPE Financing risk regarding convertible preferred shares and warrants.

02-06-2026

Plains GP Holdings, L.P. announced the promotion of Russ Montgomery to Vice President, Accounting and Chief Accounting Officer effective September 1, 2026, and the retirement of Chris Herbold as Senior Vice President, Finance and Chief Accounting Officer effective August 31, 2026.

• · Russ Montgomery, 50, previously served as Vice President, Controller of PAA since 2019.
• · Montgomery joined PAA in September 2002 and spent four years at Arthur Andersen LLP prior.
• · Chris Herbold's retirement is effective August 31, 2026, and Montgomery's promotion is effective September 1, 2026.

02-06-2026

NCS Multistage Holdings, Inc. has entered into a definitive merger agreement with Weatherford International plc, under which Weatherford will acquire NCS in an all-stock and mixed consideration transaction expected to close in the second half of 2026. Holders of more than 50% of NCS common stock have already consented to the merger, eliminating the need for further stockholder approval.

• · The Merger Agreement includes a no-shop clause and provisions for superior proposals.
• · NCS restricted stock units (RSUs) and equivalent stock units (ESUs) will be assumed by Weatherford, with terms continuing including vesting, but the Max Value Cap on ESUs will cease.
• · NCS performance stock units (PSUs) will be assumed with performance goals deemed satisfied at the greater of target and actual level as of the Merger Agreement date.
• · NCS options with an exercise price less than the value of the Share Consideration will be assumed and converted; those with an exercise price equal to or greater will be cancelled without consideration.
• · Non-employee director NCS DSUs will automatically vest and settle in NCS common stock immediately prior to the Effective Time.
• · The Outside Date for closing is May 31, 2027, after which either party may terminate if the merger has not been completed.
• · The Merger is subject to customary closing conditions including regulatory approvals, effectiveness of an S-4 registration statement, and no Material Adverse Effect.

02-06-2026

HIVE Digital Technologies reported FY2026 total revenue of $297.8 million, up 158% YoY, driven by a 164% surge in digital currency mining revenue to $278.3 million and a 94% increase in HPC revenue to $19.5 million. However, the company posted a GAAP net loss of $148.4 million, largely due to $221.3 million in non-cash charges, and Q4 FY2026 adjusted EBITDA turned negative at ($9.0) million amid hashprice compression and rising network difficulty. Despite strong annual growth, sequential Q4 Bitcoin mining revenue declined 23.9% from Q3 FY2026.

• · FY2026 average Bitcoin price was $98,040 vs $75,881 in FY2025.
• · Q4 FY2026 average Bitcoin price was $76,476, down approximately 27% from Q3 FY2026 average of ~$98,000.
• · Average network difficulty increased from 95.7T in FY2025 to 135.8T in FY2026 (42% increase).
• · Q4 FY2026 average network difficulty was 140.7T, up 27% YoY from 111.2T.
• · HPC gross margin expanded to approximately 40% in FY2026.
• · Non-cash items in FY2026 net loss: $170.4M depreciation, $50.9M net non-cash adjustments.
• · Non-cash items in Q4 FY2026 net loss: $52.7M depreciation, $30.6M non-cash adjustments.
• · Cash from operations increased 3.5-fold to $62.3M in FY2026.
• · GTA Gigafactory site: 25 acres in Toronto-Waterloo innovation corridor, targeted online in H2 2027.
• · GTA Gigafactory designed for sub-1.3 PUE with closed-loop liquid cooling, no water use.
• · Bell B200 cluster pricing: $2.90 per GPU-hour, 32% above planning rate of $2.20.
• · HIVE up-listed to TSX senior board on May 19, 2026.
• · Notes offering: $115M 0% Exchangeable Senior Notes due 2031, exchangeable at ~$2.57 per share, capped call at ~$4.92 per share.
• · HIVE's BTC-per-EH/s production ranked top among miners per Power Mining Analysis.
• · BUZZ Cloud ranked fastest download speeds per SemiAnalysis ClusterMAX 2.0.

02-06-2026

American Rebel Holdings Inc. filed a DEF 14A proxy statement detailing executive compensation, related-party transactions, and a proposal to ratify GBQ Partners LLC as independent auditor for FY2026. Key executive changes include Doug Grau stepping down as President and Interim Principal Accounting Officer on July 1, 2025, to lead a new subsidiary, American Rebel Productions, LLC. The filing also reveals significant related-party transactions, including an outstanding $400,000 director loan from Larry Sinks that remains unpaid as of December 31, 2025, and the issuance of Series D Convertible Preferred Stock to executives and directors to settle accrued bonuses and fees totaling over $2.0 million.

• · No named executive officers exercised stock options or had restricted stock units vest in FY2025 or FY2024.
• · No outstanding equity awards (unexercised options or unvested stock) were held by named executive officers as of December 31, 2025.
• · The company does not offer any annuity, pension, or retirement benefits to officers, directors, or employees.
• · Director Larry Sinks received $36,000 in consulting fees in addition to his director compensation.
• · The company leases facilities from entities owned by former Champion founder Mr. Crosby, believed to be at or below market rate.
• · As of January 1, 2025, Messrs. Ross, Lambrecht, and Grau each vested conversion rights in 10,000 additional shares of Series A Preferred Stock, convertible into 5,000,000 shares of common stock each.
• · Ross and Lambrecht each hold additional 26,250 and 6,250 shares of Series A Preferred respectively, convertible annually starting January 1, 2026 at a rate of 500 to 1.

02-06-2026

Venture Global, Inc. announced that its subsidiary, Venture Global LNG, Inc., has launched and priced a private offering of $1.125 billion in 2034 senior secured notes and $1.125 billion in 2036 senior secured notes, totaling $2.25 billion. The proceeds will be used to redeem all outstanding 8.125% senior secured notes due 2028 at a redemption price of 102.031% of principal plus accrued interest, with cash on hand covering the premium and fees. The redemption is conditional on the closing of the notes offering and is expected to occur on June 11, 2026. The filing also includes forward-looking statements highlighting risks such as potential inability to maintain profitability, need for additional capital, and ongoing legal disputes.

• · The redemption is conditioned upon the closing of the Notes Offering generating sufficient gross proceeds no less than the aggregate principal amount of the Existing Notes to be redeemed.
• · The Existing Notes were issued under an Indenture dated May 26, 2023.
• · The Notes are being offered only to qualified institutional buyers under Rule 144A and to non-U.S. investors under Regulation S.
• · The filing includes forward-looking statements with risks such as potential inability to maintain profitability, need for additional capital, and ongoing legal disputes.

02-06-2026

Vera Therapeutics announced alignment with the FDA on a revised, earlier ORIGIN 3 eGFR analysis plan to support potential full approval of atacicept in adults with IgA Nephropathy. eGFR results are now expected in Q3 2026, with a supplemental Biologics License Application submission planned for Q4 2026. The filing does not provide any financial or operational performance data, so no period-over-period comparisons are available.

• · The revised eGFR analysis plan is for the ORIGIN 3 trial in adults with IgA Nephropathy.
• · eGFR results are expected in Q3 2026.
• · Supplemental Biologics License Application submission for full approval of atacicept is planned for Q4 2026.

02-06-2026

Victoria's Secret & Co. reported strong Q1 2026 results with net sales increasing 15% YoY to $1.560B, exceeding guidance, and adjusted operating income jumping to $80M from $32M a year ago. The company raised full-year 2026 net sales guidance to $7.030-$7.130B and adjusted operating income guidance to $550-$580M, while also repurchasing 2.2M shares for $100M. However, operating income was $76M (GAAP), slightly below the non-GAAP adjusted figure, and the company's international segment saw a 44.9% sales surge, though direct sales growth was more moderate at 8.4%.

• · Q1 2026 gross profit was $584.9M vs $474.2M in Q1 2025, an increase of 23.3%.
• · SG&A expenses were $508.6M in Q1 2026, up from $454.4M in Q1 2025, but as a percentage of sales improved (32.6% vs 33.6%).
• · Interest expense decreased to $14.9M from $17.1M YoY.
• · Net income attributable to noncontrolling interest was $9.2M in Q1 2026 vs $4.4M in Q1 2025, primarily from the China joint venture.
• · The company opened 19 stores and closed 16 stores during Q1 2026, net increase of 3 stores.
• · Total company-operated stores in North America increased from 790 to 791, and China joint venture stores decreased from 65 to 64.
• · Partner-operated stores increased from 562 to 565.
• · Adore Me had 3 stores unchanged.
• · The weighted average diluted shares outstanding in Q1 2026 was 184.85M, compared to basic shares of 79.5M in Q1 2025 (due to net loss in prior year).
• · Adjusted net income for Q1 2026 was $51M vs $7M in Q1 2025.
• · Q2 2026 net sales guidance is $1.590B-$1.615B, representing ~9-11% YoY growth.
• · Full year 2025 net sales were $6.553B and adjusted operating income was $403M.

02-06-2026

Travere Therapeutics entered into a license and collaboration agreement with Everest Medicines to develop and commercialize civorebrutinib (EVER001), a covalent reversible BTK inhibitor, for all therapeutic uses outside of China and certain East/Southeast Asian countries. Travere will pay an upfront payment of $112.5 million and is eligible for up to approximately $1.03 billion in additional milestone payments, plus tiered royalties on net sales. The agreement expands Travere's pipeline into immune-mediated kidney diseases, but carries significant financial obligations and development risks.

• · The license is exclusive for the Territory (outside China and certain East/Southeast Asian countries) and includes a sublicense to third-party patents.
• · Travere cannot exercise rights outside renal disease until Everest pays a fee to third-party licensors.
• · Travere grants Everest a non-exclusive, royalty-free license to intellectual property generated under the agreement for use outside the Territory.
• · Development costs for global clinical trials will be shared between Travere and Everest.
• · Travere must use commercially reasonable efforts to develop, obtain regulatory approval for, and commercialize at least one product in the U.S. and additional major markets.
• · Royalties range from high single-digit to double-digit percentages based on annual net sales thresholds, subject to customary reductions.
• · The agreement is subject to HSR antitrust waiting period and other customary conditions.
• · Travere can terminate the agreement in its entirety or on a region-by-region basis, and can be reimbursed for the upfront payment if Everest fails to complete initial technology transfer.
• · Everest can terminate if Travere challenges licensed patents or ceases all material development for 12 consecutive months.
• · Upon early termination, Travere must grant Everest a worldwide exclusive license to its generated IP and transfer regulatory filings.

02-06-2026

Dragonfly Energy Holdings Corp., maker of Battle Born Batteries, filed a trade libel lawsuit on June 1, 2026 against William Errol Prowse IV and Prowse Publications LLC in Nevada state court. The company alleges that Prowse's monetized online content contained false and misleading statements that caused financial and reputational harm, including claims that he altered batteries before testing them. The complaint seeks damages and injunctive relief.

• · The lawsuit was filed in the Second Judicial District Court of the State of Nevada.
• · The company alleges Prowse removed structural components and ran already-damaged units out of spec during testing.
• · The company is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.

02-06-2026

Aveanna Healthcare Holdings Inc. completed the acquisition of Family First Holding, LLC for $175.5 million in cash on June 1, 2026, funded with cash on hand. The company issued a press release on June 2, 2026, announcing the completion and updating full fiscal year 2026 guidance to include the acquired operations. No negative or flat performance metrics were disclosed in this filing.

• · The acquisition was completed by wholly-owned subsidiary Pediatric Services of America, LLC.
• · The purchase price of $175.5 million is subject to customary adjustments for working capital and other items.
• · The transaction was funded entirely with cash on hand.
• · The filing references a prior Form 8-K filed on March 12, 2026, regarding the Purchase Agreement.

02-06-2026

This 8-K filing by Benchmark 2026-V21 Mortgage Trust (filed June 2, 2026) reports the entry into a Pooling and Servicing Agreement dated May 1, 2026, involving Wells Fargo Commercial Mortgage Securities, Inc. as depositor, Trimont LLC as master servicer, Rialto Capital Advisors, LLC as special servicer, Computershare Trust Company as certificate administrator, Deutsche Bank National Trust Company as trustee, and Pentalpha Surveillance LLC as operating advisor and asset representations reviewer. The servicing terms for the Del Rey Campus Mortgage Loan will differ from those for other mortgage loans, with details provided in the related Prospectus filed March 5, 2026. This is a structured finance event with no financial performance data provided, showing neither positive nor negative results.

• · The Pooling and Servicing Agreement is dated as of May 1, 2026.
• · The filing references a prior SEC filing (Prospectus under SEC File Number 333-286173-03) dated March 5, 2026, outlining servicing differences.
• · The report was signed on June 2, 2026, by Scott Epperson, CEO of GS Mortgage Securities Corporation II, as depositor.

02-06-2026

Sportsman's Warehouse Holdings reported net sales of $256.1M for the 13 weeks ended May 2, 2026, up 2.8% from $249.1M in the prior-year period. However, the company posted a net loss of $21.8M, slightly wider than the $21.3M loss a year ago, as gross profit was essentially flat at $75.8M while SG&A expenses declined modestly. Operating cash flow remained negative at -$55.4M, though improved from -$60.2M, and total debt (revolving credit + term loan) increased to $150.5M from $91.7M at year-end.

• · Hunting and Shooting Sports department accounted for 66.4% of net sales in Q1 FY26, up from 63.6% in Q1 FY25.
• · Camping department sales share declined to 7.1% from 8.5% YoY; Apparel to 5.2% from 5.8%; Footwear to 4.5% from 5.2%.
• · Merchandise inventories increased to $387.1M from $312.9M at year-end, a 23.7% rise.
• · Total assets grew to $838.0M from $762.6M at January 31, 2026.
• · Accumulated earnings (retained earnings) decreased to $77.4M from $99.3M at year-end due to the net loss.
• · Basic and diluted loss per share remained unchanged at $(0.56).
• · Weighted average basic shares outstanding increased to 38,764 from 38,144 YoY.
• · Interest expense decreased to $2.6M from $3.0M YoY.
• · Income tax expense was $1.0M vs. a benefit of $1.3M in the prior year.
• · Depreciation expense declined to $8.6M from $9.8M YoY.
• · Net borrowings on line of credit were $58.6M in Q1 FY26 vs. $67.2M in Q1 FY25.
• · Cash and cash equivalents at end of period were $2.1M, down from $3.6M a year ago.

02-06-2026

Goldman Sachs Private Credit Corp. filed a DEF 14A proxy statement for its 2026 annual meeting scheduled for July 28, 2026, seeking the election of Class III directors Timothy J. Leach (age 70) and Kaysie P. Uniacke (age 65) to three-year terms expiring in 2029. As of the May 29, 2026 record date, the company had 382,045,396.892 shares outstanding, with Charles Schwab & Co. FBO Greater Kansas City Community Foundation as the largest 5%+ holder at 27,261,693.600 shares (7.136%) and Nomura Asset Management Co. Ltd. holding 22,670,792.924 shares (5.934%). Director equity ownership is relatively small, with the board and executive officers collectively owning only 94,234.296 shares (below 1%).

• · The Board is divided into three classes with staggered three-year terms.
• · Directors are subject to a 15-year term limit and mandatory retirement at age 75 (waivable by majority of other directors).
• · The Board unanimously recommended voting FOR both nominees (Leach and Uniacke).
• · No nominee is being proposed pursuant to any agreement with the Company.
• · Kaysie Uniacke is deemed an 'interested person' due to her positions with Goldman Sachs and ownership of GS Group Inc. securities; she is the sole interested director on the Board.
• · Timothy J. Leach, if elected, would serve as an Independent Director and currently chairs the boards of the Company and GS BDC.
• · Director equity ownership is minimal: the highest individual holdings among directors are Jaime Ardila (15,730.834 shares) and Timothy J. Leach (5,192.809 shares), while four executive officers reported zero beneficial ownership.
• · All directors and executive officers as a group control less than 1% of total shares outstanding.
• · The proxy statement is available online at www.proxyvote.com with control numbers provided on the Notice.
• · Proxy materials may be requested by calling (312) 655-4419 or mailing the principal executive offices at 200 West Street, New York, NY 10282.

02-06-2026

RedCloud Holdings plc filed an F-1 registration statement with the SEC on June 2, 2026, for a secondary offering of 19,335,283 ordinary shares by selling stockholders. The company reported significant net losses of $46.2 million for FY2025 and $50.7 million for FY2024, with an accumulated deficit of $194.7 million as of December 31, 2025. While the company is listed on Nasdaq (symbol: RCT), it relies on foreign private issuer exemptions from certain corporate governance rules, and the offering provides no proceeds to the company itself.

• · The company will not receive any proceeds from the sale of shares by selling stockholders; proceeds may come only from warrant exercises.
• · Weighted average exercise price of share options is $1.06 per share; warrants have an exercise price of $0.55 per share.
• · The company relies on foreign private issuer exemptions from Nasdaq rules on board independence, quorum, and shareholder approval for equity issuances.
• · The company warns it may continue to incur net losses for the foreseeable future due to heavy investments in technology, sales, and marketing.
• · Net loss improved slightly from $50.7M in FY2024 to $46.2M in FY2025, an 8.8% reduction.

02-06-2026

Salesforce appointed Guy Wanger (age 64) as Chief Accounting Officer and principal accounting officer, effective June 15, 2026. Wanger brings extensive 38+ year career at Ernst & Young LLP where he previously served as the company's Lead Audit Engagement Partner from 2016-2021. His compensation package includes a $700,000 base salary, 70% bonus target, a $2 million sign-on cash bonus, and $9 million in restricted stock units vesting over four years.

• · Guy Wanger previously served as the company's Lead Audit Engagement Partner on behalf of EY from 2016 to 2021
• · Wanger most recently served as Partner, West Region Accounting Advisory Leader at WilliamsMarston LLC from March 2025
• · He was Chief Administrative Officer for C3 AI from September 2023 to January 2024
• · Wanger spent 38 years at EY (1985-2023), including as Audit Partner from 1996-2022 and Global Technology Industry Assurance Leader from 2012-2019
• · He is a Certified Public Accountant in California and Nevada and holds a Bachelor of Science in Commerce in Accounting from Santa Clara University
• · No family relationships with directors or executive officers, and no material interest in any reportable transactions

02-06-2026

Hennessy Capital Investment Corp. VII (HVIIU) entered into Omnibus Amendment No. 2 to its Business Combination Agreement and Promissory Note with ONE Nuclear Energy, LLC, extending the outside date for the business combination from June 30, 2026 to August 15, 2026, and increasing the principal amount of the promissory note from $300,000 to $316,975. This marks the second extension of the deal timeline, indicating potential delays in closing the merger.

• · This is the second amendment to the Business Combination Agreement and Promissory Note; the first amendment was dated March 31, 2026.
• · The original Business Combination Agreement was dated October 22, 2025, and the original Promissory Note was dated December 19, 2025.
• · The amendment was executed on June 1, 2026, and filed on June 2, 2026.
• · The increase in the promissory note principal from $300,000 to $316,975 represents a $16,975 increase (approximately 5.66%).

02-06-2026

JPMorgan Chase & Co. closed a public offering of $500,000,000 aggregate principal amount of Fixed-to-Floating Rate Notes due 2030 on June 2, 2026. These Notes are an additional issuance of, and constitute a single series with, the $2,750,000,000 aggregate principal amount of Fixed-to-Floating Rate Notes due 2030 issued on April 23, 2026. The offering was registered under the Securities Act of 1933 pursuant to a registration statement on Form S-3.

• · The Notes are an additional issuance of, and constitute a single series with, the $2,750,000,000 aggregate principal amount of Fixed-to-Floating Rate Notes due 2030 issued on April 23, 2026.
• · The offering was registered under the Securities Act of 1933 pursuant to a registration statement on Form S-3 (File No. 333-285537).
• · The legal opinion as to the legality of the Notes was provided by Simpson Thacher & Bartlett LLP and filed as Exhibit 5.1.

02-06-2026

Hovnanian Enterprises reported a net loss attributable to common stockholders of $2.953M for Q2 2026, compared to net income of $17.057M in Q2 2025, a significant decline. Total revenues decreased 2.8% YoY to $667.645M in Q2, driven by a 7.1% drop in home sales revenue to $604.188M. However, for the six-month period, net income available to common stockholders was $15.237M, down from $42.579M in the prior year, while total revenues fell 4.4% to $1.2996B. The company also reported a net loss of $0.46 per diluted share in Q2 versus earnings of $2.43 in the prior year quarter.

• · Inventory impairments and land option write-offs surged 186% to $8.75M in Q2 2026 from $3.056M in Q2 2025.
• · Land sales and other revenues increased 170% to $40.059M in Q2 2026 from $14.839M in Q2 2025.
• · Total homebuilding expenses decreased slightly to $612.775M in Q2 2026 from $617.347M in Q2 2025.
• · Financial services revenue grew 9.8% to $23.398M in Q2 2026 from $21.318M in Q2 2025.
• · Cash provided by operating activities was $73.789M for six months 2026 versus cash used of $33.576M in the prior year period.
• · The company repurchased $18.545M of treasury stock in the first six months of 2026, down from $30.396M in the same period last year.
• · Total assets increased to $2.8288B at April 30, 2026 from $2.6339B at October 31, 2025.
• · Goodwill of $31.705M was recorded at April 30, 2026, compared to zero at October 31, 2025, likely from an acquisition.
• · Net cash used in financing activities improved to $10.778M outflow from $81.021M outflow in the prior year six-month period.
• · The company had a net loss from unconsolidated joint ventures of $1.106M in Q2 2026 versus income of $9.043M in Q2 2025.

02-06-2026

VolitionRX Ltd filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders to be held on July 17, 2026. The board recommends voting FOR all five proposals, including the election of seven director nominees, ratification of Sadler, Gibb & Associates as auditor, an advisory vote on executive compensation, a reduction in authorized shares from 325,000,000 to 150,000,000, and approval of the 2026 Stock Incentive Plan. The company also effected a one-for-twenty reverse stock split in April 2026, and all share and per share amounts have been retroactively adjusted.

• · The Annual Meeting will be held at 93-95 Gloucester Place, London, W1U 6JQ, United Kingdom on July 17, 2026 at 3:30 p.m. British Summer Time.
• · Stockholders must provide valid identification and proof of ownership as of May 26, 2026 to attend in person.
• · The quorum requirement is 33 1/3% of voting power of issued and outstanding stock entitled to vote.
• · Directors are elected by a plurality of votes; other proposals require a majority of votes cast.
• · The reverse stock split was effected on April 28, 2026, and shares began trading on a post-split basis that same day.
• · The company has 8,627,191 shares outstanding held by approximately 166 stockholders of record as of May 26, 2026.
• · Proposal 4 seeks to reduce authorized shares from 325,000,000 to 150,000,000, but the board may delay or abandon filing the amendment even if approved.

02-06-2026

Maui Land & Pineapple Company, Inc. (MLP) entered into a Purchase and Sale Agreement on May 27, 2026, to sell 8.783 acres of land (Lot 2-D) and up to 3.5 acres of adjacent land in Kapalua, Maui, to DC Kapalua 1 Property, LLC for a base price of $10,000,000 plus $1,138,565 per acre for the additional land. The agreement includes a 90-day due diligence period, customary earnest money deposits, and conditions related to governmental approvals, with potential termination rights if approvals are not secured. The transaction also provides for a non-exclusive trademark license, a master lease of retail space to MLP, and access to amenities for Kapalua Club members.

• · The Purchase Agreement includes a non-exclusive license to use certain MLP trademarks, a master lease of new street front retail space in Kapalua Village from Buyer to MLP, and access to amenities for Kapalua Club members.
• · Earnest money deposits become nonrefundable based on time elapsed after the Acceptance Date; if Buyer terminates or fails to deliver Acceptance Notice during due diligence, all deposits are refundable.
• · The full Purchase Agreement will be filed as an exhibit to MLP's Quarterly Report on Form 10-Q on or before August 14, 2026.

02-06-2026

BlackRock Technology & Private Equity Term Trust (BTX) filed a definitive proxy statement (DEF 14A) with the SEC on June 2, 2026, for its upcoming annual meeting scheduled for July 22, 2026. The filing covers standard proxy matters including director elections, ratification of auditors, and advisory votes on executive compensation. No specific financial results or performance metrics are disclosed in this filing.

• · Filing type: DEF 14A (definitive proxy statement)
• · Annual meeting date: July 22, 2026
• · SEC file number: 811-23625
• · Central Index Key (CIK): 0001836057
• · State of incorporation: Maryland (MD)
• · Fiscal year end: December 31
• · Former name: BlackRock Innovation & Growth Term Trust (changed April 6, 2023)
• · Business address: Bellevue Parkway, Wilmington, DE 19808
• · Business phone: (800) 882-0052

02-06-2026

Energy Services of America Corporation (ESOA) announced on June 2, 2026 that management will present at the East Coast IDEAS Investor Conference on June 11, 2026 in New York, NY. The filing is an 8-K providing notice of this investor conference participation and includes a press release as an exhibit. No financial results or material operational changes were disclosed.

• · The conference is the East Coast IDEAS Investor Conference.
• · The conference will be held at The Westin Times Square in New York, NY.
• · The press release is dated June 2, 2026 and is furnished as Exhibit 99.1.
• · The filing is not deemed filed for purposes of the Securities Exchange Act of 1934.

02-06-2026

Hertz Global Holdings, Inc., through its subsidiary Hertz Vehicle Financing III LLC, issued $500 million in Series 2026-1 Rental Car Asset Backed Notes across five tranches (Class A through E) with interest rates ranging from 5.09% to 9.64%, secured by rental car assets. The notes were issued under a base indenture dated June 29, 2021, with The Bank of New York Mellon Trust Company serving as trustee and securities intermediary. This securitization provides Hertz with significant new financing, but the high interest rates on the lower-rated tranches (Class D at 7.91% and Class E at 9.64%) reflect elevated credit risk and borrowing costs.

• · The notes are secured by rental car assets under a base indenture dated June 29, 2021, as amended.
• · Class A/B/C Notes have minimum denominations of $100,000; Class D Notes $250,000; Class E Notes $3,250,000.
• · The Series 2026-1 Supplement was dated May 28, 2026, and filed on June 2, 2026.
• · The notes are subject to subordination provisions, with Class B through E notes subordinated to Class A.
• · The issuance includes provisions for optional redemption, amortization events, and priority of payments.

02-06-2026

Veri MedTech Holdings, Inc. filed Amendment No. 4 to its S-1 registration statement on June 2, 2026, for a firm commitment IPO of up to 3,750,000 shares of common stock at an initial public offering price of $4.00 per share, with total gross proceeds of $15.0 million. The company currently trades on the OTCID market under the symbol VRHI at $1.00 per share (as of June 2, 2026) and intends to list on the NASDAQ Capital Market, though no assurance of approval is given. The offering is contingent on NASDAQ listing approval, and after the offering, executives will hold over 50% voting power, making the company a 'controlled company,' though it voluntarily intends to comply fully with NASDAQ corporate governance requirements.

• · The company is a 'smaller reporting company' and an 'emerging growth company' under the JOBS Act, electing to use reduced public company reporting requirements.
• · The Series A Preferred Stock (100 shares held by the CEO/President) represents 80% of the voting power, regardless of the number of shares outstanding.
• · The common stock offered does not represent equity interests in the company's subsidiaries; the company is a holding company.
• · The offering is contingent on NASDAQ Capital Market listing approval; if not approved, the offering will not be consummated.
• · The underwriter's warrants have an exercise price of $4.40 per share (110% of the offering price) and cover 345,000 shares (excluding over-allotment).
• · The company has granted the underwriter a 45-day option to purchase up to 562,500 additional shares at the IPO price less discounts.

02-06-2026

NexPoint Diversified Real Estate Trust held its Annual Meeting on June 2, 2026, where shareholders approved the 2026 Long Term Incentive Plan, ratified KPMG LLP as auditor for 2026, and elected all seven trustee nominees. A shareholder proposal to liquidate the company's assets was overwhelmingly rejected, with 25.2 million votes against versus 4.6 million in favor. However, the advisory vote on executive compensation passed with 27.0 million for and 2.5 million against, indicating some shareholder dissent.

• · All seven trustee nominees were elected with votes for ranging from 24,208,120 (Scott Kavanaugh) to 27,712,602 (Brian Mitts).
• · The advisory vote on executive compensation passed with 26,993,180 for, 2,516,601 against, and 436,991 abstentions.
• · The 2026 LTIP was approved with 26,945,964 for, 2,833,644 against, and 167,164 abstentions.
• · Ratification of KPMG LLP as auditor received 42,760,080 for, 1,514,886 against, and 108,464 abstentions, with no broker non-votes.
• · The shareholder proposal to liquidate the company's assets was not approved: 4,570,997 for, 25,160,407 against, 215,368 abstentions.
• · The issuance of common shares upon conversion or redemption of Series B Preferred Shares was approved with 27,382,186 for, 2,442,145 against, 122,441 abstentions.
• · Broker non-votes were 14,436,658 on all matters except the ratification of KPMG (which had 0 broker non-votes).

02-06-2026

Workiva Inc. held its Annual Meeting on May 28, 2026, where stockholders elected three Class III directors (Michael M. Crow, R. Scott Herren, and Julie Iskow) for terms expiring in 2029, and approved the amendment and restatement of the 2014 Equity Incentive Plan, increasing authorized shares from 17,760,000 to 21,660,000 (an additional 3,900,000 shares). The advisory vote on executive compensation passed with 51,575,404 votes in favor, but a significant 22,289,983 votes were against, indicating notable shareholder dissent.

• · The advisory vote on executive compensation (Say-on-Pay) received 22,289,983 votes against, representing approximately 30% of votes cast (excluding broker non-votes), a significant dissent level.
• · Julie Iskow had the highest number of withheld votes among directors at 20,448,075.
• · R. Scott Herren received the strongest support with 73,726,838 votes for and only 316,497 withheld.
• · The equity plan amendment passed with 62,218,607 votes for and 11,806,408 against.

02-06-2026

Liberty Global Ltd. filed a Form 8-K on June 2, 2026, to furnish a press release under Regulation FD Disclosure (Item 7.01). The filing does not contain any financial results or quantitative data, only the disclosure of the press release as an exhibit.

• · The filing is furnished under Item 7.01 and is not deemed 'filed' for Section 18 of the Exchange Act.
• · Exhibit 99.1 is a press release dated June 2, 2026, but its content is not included in this filing.

02-06-2026

BlackRock ESG Capital Allocation Term Trust (ECAT) filed definitive additional proxy soliciting materials urging shareholders to vote on the WHITE card and FOR all nine Board nominees ahead of the upcoming meeting. The filing highlights that leading proxy advisors Glass Lewis and Egan-Jones recommend voting FOR all nominees, and warns against risking significant changes to the investment and consistent distributions. The Board is soliciting votes for the election of Class I, Class II, and Class III Board Member Nominees.

• · The filing is a DEFA14A (definitive additional proxy materials) filed on June 2, 2026.
• · Shareholders can vote online, by phone, or by mail using the enclosed WHITE card.
• · The proxy solicitor is Georgeson LLC, reachable toll-free at 1-866-961-8444.
• · The fund is a closed-end fund; shares trade on a stock exchange at market price, which may trade at a premium or discount to NAV.
• · The material is for existing shareholders only and is not an advertisement.

02-06-2026

BlackRock Private Investments Fund and BlackRock HPS Credit Strategies Fund are holding a joint special shareholder meeting on July 22, 2026, to elect seven Board Nominees. The Boards unanimously recommend voting 'FOR' all nominees, as less than a majority of current Board Members were elected by shareholders following a recent retirement. The meeting will be held virtually, and shareholders are encouraged to vote by telephone, internet, or proxy card.

• · Record Date for voting eligibility is May 26, 2026.
• · Meeting will be held virtually at meetnow.global/MSZHAHD; shareholders can log in starting at 10:30 a.m. ET on July 22, 2026.
• · Beneficial shareholders must register in advance by emailing a legal proxy to shareholdermeetings@computershare.com by 5:00 p.m. ET three business days before the meeting.
• · Proxy voting deadline is 11:59 p.m. ET on July 21, 2026.
• · The election is required because less than a majority of current Board Members were elected by shareholders after a recent retirement.
• · If elected, all Board Members will have been elected by shareholders, providing more flexibility for future vacancies.

02-06-2026

Paramount Gold Nevada Corp. announced the results of an updated feasibility study for its 100%-owned Grassy Mountain Gold Project in Oregon, filed via an 8-K on May 28, 2026. The study was prepared in accordance with SEC Regulation S-K Subpart 1300. No specific financial figures or comparative performance data were disclosed in the filing.

• · The feasibility study is for the 100%-owned Grassy Mountain Gold Project located in Malheur County, Oregon.
• · The study was prepared in accordance with subpart 1300 of Regulation S-K.
• · The press release is furnished as Exhibit 99.1 and contains forward-looking statements subject to risks and uncertainties.

02-06-2026

Cantor Equity Partners VII, Inc., a blank check company, filed Amendment No. 1 to Form S-1 on June 2, 2026, for an initial public offering of 25,000,000 Class A ordinary shares at $10.00 per share, aiming to raise $250,000,000. The sponsor has purchased 7,187,500 Class B founder shares for $25,000 (approx. $0.003 per share) and will also purchase 600,000 Class A shares privately for $6,000,000. However, the sponsor's founder shares carry substantial dilution risk for public shareholders due to the low cost basis and anti-dilution provisions; also, the company has not yet identified any business combination target, and if it fails to complete a combination within 24 months, it will liquidate and redeem public shares.

• · The company is incorporated in the Cayman Islands and is a blank check company (SIC 6770).
• · Underwriters have a 45-day option to purchase up to 3,750,000 additional Class A shares to cover over-allotments.
• · Unlike some SPAC IPOs, this offering does not include warrants; investors receive only Class A ordinary shares.
• · The sponsor's Class B founder shares have anti-dilution provisions that could cause additional dilution to public shareholders upon conversion.
• · Prior to the initial business combination, only Class B holders may appoint/remove directors and vote on continuing the company outside Cayman Islands; on other matters, both classes vote together as a single class.
• · Public shareholders may redeem their shares upon completion of the initial business combination, but holders exceeding 15% of the offering may be restricted from redeeming more than 15% without company consent.

02-06-2026

BlackRock MuniYield Pennsylvania Quality Fund (MPA) filed a definitive proxy statement (DEF 14A) on June 2, 2026, for its annual shareholder meeting to be held virtually on July 22, 2026. The sole proposal is the election of Board Nominees, unanimously recommended by the Board. The Fund will bear all proxy costs, including an estimated $11,800 fee to proxy solicitor Georgeson LLC.

• · The annual meeting will be held virtually on July 22, 2026 at 10:30 a.m. Eastern Time.
• · Record date for shareholders is May 26, 2026.
• · Shareholders can vote by telephone, internet, ProxyVote app, mail, or at the virtual meeting.
• · Beneficial shareholders must register in advance to vote at the meeting by submitting a legal proxy to shareholdermeetings@computershare.com by 5:00 p.m. ET three business days before the meeting.
• · If a proxy card is submitted without voting instructions, shares will be voted FOR the Board Nominees.
• · The Fund's Board has unanimously approved the nominees and recommends a vote FOR each.
• · The Fund will bear all costs of the proxy solicitation, including legal and auditor fees.

02-06-2026

Senior Credit Investments, LLC declared a distribution of $17.0106 per common unit, payable on June 18, 2026, to unitholders of record as of May 29, 2026. The distribution will be paid in cash. No prior period comparison or other financial metrics were provided in this filing.

• · Distribution payable on June 18, 2026.
• · Record date: close of business on May 29, 2026.
• · Distribution will be paid in cash.

02-06-2026

Global Medical REIT Inc. (GMRE-PB) filed an 8-K on June 2, 2026, announcing the Seventh Amendment to the Agreement of Limited Partnership of Chiron Real Estate LP, which designates up to 1,000,000 shares of 6.00% Series C Convertible Preferred Units. The Series C Preferred Units have a Base Liquidation Preference of $100 per unit and an initial annual return of 6.00%, which can increase to up to 12.00% after four years if outstanding. The units rank senior to common and LTIP units but junior to existing and future indebtedness, with no stated maturity and no mandatory redemption.

• · The Series C Preferred Units have no stated maturity and are not subject to any sinking fund or mandatory redemption.
• · Distributions are cumulative and payable quarterly in arrears on March 31, June 30, September 30, and December 31, beginning September 30, 2026.
• · The Series C Preferred Return increases from 6.00% to 8.00% after four years, then by 2.00% annually up to a maximum of 12.00%.
• · The units rank senior to Junior Units (common units, LTIP units) and on parity with Series A and Series B Preferred Units, but junior to all existing and future indebtedness.
• · The amendment is tied to the issuance of up to 1,000,000 shares of Series C Preferred Stock by the Parent REIT, with net proceeds contributed to the Partnership in exchange for the Series C Preferred Units.

02-06-2026

Kyverna Therapeutics held its 2026 Annual Meeting on May 27, 2026, with approximately 73% of outstanding shares represented. Stockholders elected Ian Clark and Christi Shaw as Class II directors and ratified BDO USA, P.C. as independent auditor for fiscal 2026. The meeting had strong quorum and all proposals passed with overwhelming support.

• · Ian Clark received 31,505,902 votes for and 3,255,231 votes withheld, with 9,225,874 broker non-votes.
• · Christi Shaw received 34,528,865 votes for and 232,268 votes withheld, with 9,225,874 broker non-votes.
• · Ratification of BDO USA, P.C. as auditor passed with 43,830,300 votes for, 80,223 against, and 76,484 abstentions.
• · The record date for the meeting was March 30, 2026.

02-06-2026

Janus Investment Fund is soliciting shareholder votes for a Special Meeting via Alliance Advisors, with polls closing soon. The filing includes sample outreach messages urging shareholders to vote to stop further contact.

• · Shareholders can vote via QR code or call 1-855-206-2338.
• · A video message from Janus Henderson leadership is available.
• · Text STOP to end outreach messages.

02-06-2026

Arvinas, Inc. announced a portfolio re-prioritization and plans to out-license its KRAS G12D-targeting PROTAC, ARV-806, after completing its Phase 1 monotherapy dose-escalation trial and sharing data in 2026. The company will use a new investor presentation beginning June 2-3, 2026, including at the Jefferies Global Healthcare Conference. Arvinas reaffirmed that its cash, cash equivalents, and marketable securities as of March 31, 2026, are sufficient to fund operations into the second half of 2028. The strategic pivot implies a narrower internal pipeline but no new clinical results were disclosed.

• · The company completed dose escalation enrollment of the Phase 1 trial for ARV-806 in Q2 2026.
• · Arvinas intends to seek an out-licensing agreement for any further development of ARV-806 beyond the ongoing monotherapy dose escalation.
• · The investor presentation (Exhibit 99.1) is furnished under Item 7.01 and is not deemed filed for SEC liability purposes.
• · The current report also contains forward-looking statements and disclaims any obligation to update them.

02-06-2026

OpenPayd Global Holdings Ltd, a provider of universal financial infrastructure for the digital economy, announced a planned business combination with SPAC Titan Acquisition Corp. The transaction implies a pro forma enterprise value of approximately $881.2 million and is expected to result in a NASDAQ listing in 2026. OpenPayd reports strong organic growth with $85M+ ARR and $240B+ annualized transaction volume as of March 2026, but the PIPE financing of $100M is not yet committed, and the company's gross profit margin has declined from 84% in FY23A to 78% in FY25A, with EBITDA margins remaining modest at 21% in FY25A.

• · OpenPayd has never raised external capital to date, funding growth entirely organically.
• · The company holds licenses in the USA (44 MTLs), UK (EMI), EEA (FI, VASP), Canada (Fin-Trac Registration), South Africa (AFSP), and France (VFA, MoM, Malta EMI).
• · Revenue mix for FY26F: Transaction fees 41%, FX margin 24%, Recurring fees 14%, Interest revenue 13%, Operational fees 5%, Setup fees 3%.
• · Planned capital deployment: 50% ($75M) growth capital, 40% ($60M) strategic M&A (20% cash/80% shares), 10% ($15M) foundation & balance sheet strength.
• · Pro forma ownership: OpenPayd rollover 64.3% (80.0M shares), Public shareholders 22.2% (27.6M), PIPE 8.0% (10.0M), Sponsor shares 4.7% (5.9M), Founder shares 0.8% (1.0M).
• · Warrants: 13.8M SPAC warrants and 8.1M Private Placement warrants, all with $11.50 strike price.
• · The PIPE of $100M is not yet committed and is subject to being raised.
• · EBITDA improved from negative ($8M) in FY23A to positive $8M in FY24A and $12M in FY25A, but EBITDA margin is forecast to decline from 21% in FY25A to 18% in FY26F.
• · Gross profit margin declined from 84% in FY23A to 78% in FY25A, but is forecast to rebound to 92% in FY26F.
• · The company's platform boasts >99.995% uptime.

02-06-2026

VisionWave Holdings, Inc. announced the appointment of Einav Eliraz as Chief Financial Officer of its wholly-owned subsidiary VisionWave IL Ltd., effective June 1, 2026. Mr. Eliraz brings over 20 years of public company finance experience, including roles at Nano Dimension, Cellebrite, and Raval ACS. His compensation includes a gross monthly salary of NIS 50,000, customary Israeli benefits, and a performance bonus, plus a proposed grant of options to purchase 500,000 shares of common stock (subject to approvals). The appointment is expected to support the company's growth, acquisition strategy, and public company compliance, but no financial performance metrics or prior-period comparisons are provided in this filing.

• · Mr. Eliraz holds an MBA in Finance from the Hebrew University of Jerusalem and a B.A. in Accounting from Tel Aviv University, and is a Certified Public Accountant in Israel.
• · The option grant is subject to approval by the Board, Compensation Committee, stockholders if required, and compliance with Nasdaq rules.
• · There are no family relationships between Mr. Eliraz and any director or executive officer of the Company.
• · No transactions involving Mr. Eliraz require disclosure under Item 404(a) of Regulation S-K.

02-06-2026

Vista Credit Strategic Lending Corp. held its annual meeting on May 28, 2026, where shareholders elected Stephen Riddick as Class III director and ratified Deloitte & Touche LLP as independent auditor for FY 2026, both with overwhelming support. The company announced a May 2026 distribution for Class I ($0.15000 net) and Class S ($0.13614 net) shares, payable on June 25, 2026; however, no Class D shares are outstanding, and the distribution amounts per share are unchanged from prior monthly levels, indicating stable but flat payout performance.

• · Record date for the meeting was March 30, 2026.
• · Stephen Riddick received 28,073,001 votes for (61 against, 120,951 abstentions).
• · Ratification of Deloitte & Touche LLP received 28,081,520 votes for (0 against, 112,493 abstentions).
• · May 2026 distribution record date was May 29, 2026; payment date is June 25, 2026.
• · Class I distribution: gross $0.15000, no servicing/distribution fee, net $0.15000.
• · Class S distribution: gross $0.15000, $0.01386 fee, net $0.13614.
• · No Class D shares were outstanding as of May 29, 2026.
• · The registrant is an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.

02-06-2026

Varonis Systems held its 2026 Annual Meeting on June 1, 2026, where stockholders re-elected four directors, approved executive compensation on an advisory basis, ratified the appointment of Kost Forer Gabbay & Kasierer (EY) as independent auditor for FY2026, and approved an increase of 6,402,279 shares under the 2023 Omnibus Equity Incentive Plan. All proposals passed, though Proposal 4 (equity plan share increase) received the lowest support with approximately 9.7 million votes against.

• · Proposal 4 (equity plan share increase) had the highest opposition with 9,715,526 votes against and 70,090 abstentions, representing about 10.6% of votes cast (excluding broker non-votes).
• · Ratification of auditor (Proposal 3) passed with overwhelming support: 96,222,394 for, 3,931,624 against, 42,102 abstain, and no broker non-votes.
• · Advisory vote on executive compensation (Proposal 2) received 83,058,191 for, 7,994,373 against, and 114,288 abstain, indicating some shareholder dissent.
• · All four director nominees were elected with over 83 million votes each; Avrohom J. Kess received the highest withheld votes at 8,136,069.